Cantitate/Preț
Produs

Deprescribing and Polypharmacy in an Aging Population

Autor Ali Elbeddini
en Limba Engleză Paperback – 21 aug 2023
Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population.

  • Emphasizes the importance of involving a multidisciplinary team in deprescribing efforts
  • Identifies barriers and enablers for the implementation of deprescribing programs
  • Develops strategies to address barriers and optimize enablers for deprescribing implementation
Citește tot Restrânge

Preț: 81296 lei

Preț vechi: 102542 lei
-21% Nou

Puncte Express: 1219

Preț estimativ în valută:
15558 16161$ 12924£

Carte tipărită la comandă

Livrare economică 27 ianuarie-10 februarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 18580 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323991384
ISBN-10: 0323991386
Pagini: 166
Dimensiuni: 152 x 229 x 11 mm
Greutate: 0.23 kg
Editura: ELSEVIER SCIENCE

Public țintă

Healthcare professionals involved in the circle of care and Pharmacy and medical school students & residents and professors
Hospital leadership and Policy makers

Cuprins

1. A global overview of the current state of deprescribing 2. Health policies and deprescribing: An introduction to health policies, knowledge translation, and the barriers, challenges, and enablers to health policy implementation 3. Deprescribing is an essential part of prescribing 4. Deprescribing in school curriculums: An overview of current education standards and what should be changed 5. The role of the multidisciplinary healthcare team in deprescribing 6. Looking to the future: Artificial intelligence in enhancing patient care 7. Challenges/barriers of deprescribing during Covid-19 8. Deprescribing in pallative care and Alzheimer's patients: Optimizing medication use for improved quality of life

Recenzii

"This publication serves as an overview of important concepts in medication use, such as polypharmacy and deprescribing... [And] provide[s] an assessment of current practices, limitations, and barriers to identify polypharmacy-related drug events for healthcare providers (HCPs) practicing in global healthcare settings... useful, but specific to the impact of polypharmacy on adverse drug events and challenges to implement deprescribing. The tools and strategies presented can be used to make meaningful changes to health care curriculum and health care policy." --©Doody’s Review Service, 2024, Susan Romann, PharmD, BCGP (Temple University School of Pharmacy)